Emergent Biosolutions(CH:ER4)
CHF 5.04+0.24 (+4.89%)
CH:ER4
Emergent Biosolutions Revenue
CHF 5.04
At close:+0.24 (+4.89%)
Emergent Biosolutions (ER4) Revenue
2 Followers
Emergent Biosolutions Revenue
Emergent Biosolutions had a revenue of 110.00M in the quarter ending Sep 30, 2026, with -53.05%. This bring the company's revenue in the last twelve months to 649.10M, Decreased 15.72%. In the fiscal year ending Dec 31, 2025, Emergent Biosolutions had annual revenue of 742.90M with -28.81% growth.
- Revenue (ttm)
- 649.10M
- Revenue Growth
- -23.26%
- P/S Ratio
- 0.35
- Revenue/Employee
- CHF 825,444
- Employees
- 900
- Market Cap
- CHF 258.88M
Revenue Chart
Emergent Biosolutions Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 742.90M | -300.70M | -28.81% |
| Dec 31, 2024 | 1.04B | -5.70M | -0.54% |
| Dec 31, 2023 | 1.05B | -68.20M | -6.10% |
| Dec 31, 2022 | 1.12B | -656.10M | -36.99% |
| Dec 31, 2021 | 1.77B | 196.30M | 12.45% |
| Dec 31, 2020 | 1.58B | 471.30M | 42.61% |
| Dec 31, 2019 | 1.11B | 323.60M | 41.36% |
| Dec 31, 2018 | 782.40M | 221.50M | 39.49% |
| Dec 31, 2017 | 560.90M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.